Background/Aims: Long noncoding RNAs (lncRNAs) play important roles in stem cell differentiation. However, their role in osteogenesis of human adipose-derived stem cells (ASCs), a promising cell source for bone regeneration, remains unknown. Here, we investigated the expression profile and potential roles of lncRNAs in osteogenic differentiation of human ASCs. Methods: Human ASCs were induced to differentiate into osteoblasts in vitro, and the expression profiles of lncRNAs and mRNAs in undifferentiated and osteogenic differentiated ASCs were obtained by microarray. Bioinformatics analyses including subgroup analysis, gene ontology analysis, pathway analysis and co-expression network analysis were performed. The function of lncRNA H19 was determined by in vitro knockdown and overexpression. Quantitative reverse transcription polymerase chain reaction was utilized to examine the expression of selected genes. Results: We identified 1,460 upregulated and 1,112 downregulated lncRNAs in osteogenic differentiated human ASCs as compared with those of undifferentiated cells (Fold change ≥ 2.0, P < 0.05). Among these, 94 antisense lncRNAs, 85 enhancer-like lncRNAs and 160 lincRNAs were further recognized. We used 12 lncRNAs and 157 mRNAs to comprise a coding-non-coding gene expression network. Additionally, silencing of H19 caused a significantly increase in expression of osteogenesis-related genes, including ALPL and RUNX2, while a decrease was observed after H19 overexpression. Conclusion: This study revealed for the first time the global expression profile of lncRNAs involved in osteogenic differentiation of human ASCs and provided a foundation for future investigations of lncRNA regulation of human ASC osteogenesis.
Introduction
Osteoporosis is a common, age-related skeletal disease characterized by the loss of bone mass and deficits in bone quality, leading to low bone strength and increased risk of fractures [1] . Current treatments for osteoporosis are predominantly focused on pharmacological drugs, although transplantation of mesenchymal stem cells (MSCs) has become an attractive approach during the past decade [2] [3] [4] . Bone marrow mesenchymal stem cells (BMSCs) have been considered an ideal cell source for bone regeneration for years; however, increasing evidence suggests that the proliferative ability and osteogenic differentiation capability of BMSCs decrease with age or under other osteoporotic conditions. Meanwhile, this is always accompanied by the generation of additional marrow adipose tissue [5] [6] [7] . Recently, adiposederived stem cells (ASCs) have been studied extensively as an alternative cell source to BMSCs due to their widespread sources, easy access and multipotency [3, 8] . More importantly, ASCs isolated from aged or osteoporotic humans and animals maintain their osteogenic differentiation capability, making them more promising for autologous cell-based therapy for osteoporosis [9] [10] [11] . Their osteogenic differentiation is regulated at transcriptional, posttranscriptional and epigenetic levels. However, the precise molecular mechanisms related to osteogenesis require further investigation.
Long noncoding RNAs (lncRNAs) are a novel subset of noncoding RNAs that are over 200 nucleotides in length. Increasing evidence shows that lncRNAs are involved in diverse physiological processes, as well as pathological processes, via different mechanisms [12, 13] . Interestingly, numerous lncRNAs are restricted to specific cell lineages, indicating their potential roles in the determination of cell fate [14] . Previous studies suggested that lncRNAs play important roles in MSC differentiation, including several publications that investigated the expression and potential role of lncRNAs in the osteogenesis of human BMSCs, mouse C3H10T1/2 MSCs and other types of MSCs [15] [16] [17] [18] [19] [20] [21] [22] . Most recently, one study demonstrated an inhibitory role of lncRNA-MIR31HG in osteogenic differentiation of human ASCs under an inflammatory microenvironment [23] . However, there remains a lack of data concerning the global expression and potential function of lncRNAs in the differentiation of human ASCs into osteoblasts.
In this study, we compared the expression profiles of lncRNAs between osteogenic differentiated human ASCs and undifferentiated cells by microarray analysis, followed by bioinformatics analyses and in vitro experiments used to explore the potential roles of these differentially expressed lncRNAs in osteogenesis. These findings provided a primary foundation for future investigations of lncRNA regulation of ASC osteogenesis.
Materials and Methods

Cell culture
The use of human cells was approved by the Ethics Committee of The First Affiliated Hospital of Sun Yat-sen University, China ([2013]C-260). Human ASCs derived from the fat tissue of different healthy donors (aged 18-45-years, n = 4) were purchased from Cyagen (Suzhou, China). ASCs were maintained in OriCell TM Human MSC Growth Medium containing 10% MSCs-Qualified Fetal Bovine Serum (FBS), 1% PenicillinStreptomycin and 1% Glutamine (Cyagen, China) under 37˚C, 5% CO 2 conditions. The medium was replaced every 3 days, and when cells reached 80% confluence, they were passaged using 0.25% trypsin/EDTA (Gibco, USA).
Osteogenic differentiation of ASCs
Third passage human ASCs were seeded into six-well plates at a density of 2 x 10 4 cells/cm 2 , and cells were cultured in standard growth medium until they reached 50% to 70% confluence. The medium was then changed to OriCell TM human ASC Osteogenic Differentiation Medium (Cyagen) containing 10% FBS, 1% Penicillin-Streptomycin, 10 mM L-glutamine, 50 μM L-ascorbic acid, 10 mM beta-glycerophosphate and 100 nM dexamethasone. The differentiation medium was carefully replaced every 3 days. After a 14-
Transient transfection
The H19 siRNA and scramble negative control siRNA were purchased from RiboBio (Guangzhou, China). The target sequences of the three siRNAs against H19 are as follows: si-H19-1, GACACCATCGGAACAGCAG; si-H19-2, CCCGTCCCTTCTGAATTTA; si-H19-3, CGTGACAAGCAGGACATGA. The H19 overexpression plasmid pEX-3-H19 was constructed by cloning the entire H19 coding fragment into the XhoI/EcoRI site of the pEX-3 vector. The pEX-3-H19 plasmid and pEX-3 empty plasmid were designed and synthesized by GenePharma (Shanghai, China). Human ASCs cultured in antibiotic-free growth medium were allowed to grow to 60% to 70% confluence prior to transfection with 50 nM siRNA or 50 nM plasmid using Lipofectamine ® 2000 Transfection Reagent (Invitrogen, USA) according to manufacturer's instructions. After 48 hours, cells were induced to osteogenic differentiation for 3 days as above and total RNA was extracted for qRT-PCR analysis.
RNA isolation and quality control
Total RNA from human ASCs was extracted using Trizol reagent (Invitrogen) according to the instructions of manufacturer. A NanoDrop ND-1000 spectrophotometer was used for measuring RNA quantity and quality, and agarose gel electrophoresis was used to examine RNA integrity.
Microarray hybridization
Human LncRNA Microarray V3.0 (Arraystar, USA) used in this study is a commercial array (Agilent Design ID: Agilent-045997) designed for the global profiling of human lncRNAs and mRNAs. Approximately 30,586 lncRNAs and 26,109 mRNAs can be detected using this microarray. According to the most highlyrespected public transcriptome databases, including Refseq, UCSC knowngenes, Genecode and landmark publications, lncRNAs were carefully constructed on the microarray. Each individual transcript was identified by a specific exon or splice junction probe. Negative probes and positive probes were also included in the array for hybridization quality control.
Sample preparation and array hybridization were modified from the protocol for Agilent One-Color Microarray-Based Gene Expression Analysis (Agilent Technology, USA) and utilized the Arraystar Flash RNA Labeling Kit (Arraystar, USA). Briefly, purified RNA was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts by utilizing a mixture of oligo dT and random primers to avoid 3' bias. After measuring concentration and specific activity, the fluorescent cRNAs were hybridized onto the lncRNA array slide, followed by the arrays being washed, fixed and scanned using a DNA microarray scanner (Agilent Technology). Feature Extraction Software v11.0.1.1 (Agilent Technology) was used to extract raw data from the acquired array images.
qRT-PCR
For detection of mRNAs and lncRNAs, 1 μg of total RNA was reversely transcribed to cDNA using random hexamer primer and SuperScript III Reverse Transcriptase (Invitrogen). Then, qRT-PCR was performed on a Bio-Rad CFX96 System (Bio-Rad, USA) using SYBR Premix Ex Taq TM II (Takara, Japan) according to manufacturer's instructions. The reaction volume contained 10 μL SYBR Premix Ex Taq II (2x), 0.8 μL of forward primer and reverse primer (10 μM), 2 μL template cDNA and 6.4 μL dH 2 O to a final volume of 20 μL. The reaction conditions were as follows: denaturation at 95°C for 5 seconds, followed by 40 cycles of 95°C for 5 seconds and 60°C for 30 seconds. Melting curve analysis was performed from 65°C to 95°C with an increment of 0.5°C. All qRT-PCR reactions were performed in triplicate. GAPDH expression was used to normalize expression of lncRNAs and mRNAs. The 2 -ΔΔCt method was used to calculate relative gene expression. Primers for qRT-PCR were designed with Primer 5.0 and BLAST was used to determine individual specificity. Amplification efficiency was determined by standard curve for each primer. The templates for standard curve were the PCR products which were synthetized from cDNA of undifferentiated human ASCs and purified via agarose gel electrophoresis. Ten 10-fold serial dilutions of templates were prepared and 1/ (dilution factor) was used as a concentration. Standard curve was obtained by plotting Ct value on the X-axis Table S1 ).
Bioinformatics analysis and statistical analysis
After quantile normalization of the raw data, lncRNAs and mRNAs flagged as "Present" or "Marginal" in at least four out of eight samples were used for subsequent data analysis with GeneSpring GX v12.1 software package (Agilent Technology). Differentially expressed lncRNAs and mRNAs between two samples in each pair of cells were identified through Fold Change filtering (Fold Change ≥ 2.0). The significance of differences in expression levels between the two groups was evaluated by paired t-test. And P-value filtering (P < 0.05) was used to identify significant differentially expressed transcripts. Hierarchical Clustering and combined analysis were performed using homemade scripts. Euclidean distance and average linkage rule were used for clustering. To explore the potential functions of the dysregulated lncRNAs, classification and subgroup analysis was performed. Both gene ontology (GO) analysis and pathway analysis were carried out to determine the roles of the differentially expressed mRNAs. Fisher's exact test was used to test the significance of GO terms and Pathway identifiers enrichment in the differentially expressed gene list. Pearson's product-moment correlation coefficient was used to assess correlations between the expression of lncRNAs and co-expressed coding transcripts. Those dysregulated lncRNAs and mRNAs exhibiting Pearson's coefficients >0.99 were selected to construct a coding-non-coding gene co-expression network (CNC network) using Cytoscape. Microarray and bioinformatics analyses were performed by KangChen Bio-tech (Shanghai, China). For qRT-PCR validation experiment, Spearman's correlation coefficients were used to correlate the fold changes measured by qPCR and microarray. In cases of multiple-group analysis, one-way analysis of variance (ANOVA) followed by Dunnett-t test was conducted. A value of P < 0.05 was considered statistically significant.
Results
Differentially expressed lncRNAs in osteogenic differentiated human ASCs
After a 14-day osteogenic induction, alizarin red staining indicated that calcium deposition was positive, and the expression of osteogenesis-related genes, including collagen type I alpha 1 chain (COL1A1), alkaline phosphatase liver/bone/kidney (ALPL) and runtrelated transcription factor 2 (RUNX2) was significantly increased in differentiated cells as compared with undifferentiated human ASCs (Fig. 1) . These results confirmed osteogenic differentiation.
We identified a total of 17,246 lncRNAs expressed in human ASCs according to microarray analysis. Hierarchical clustering analysis showed homogeneous lncRNA expression profiles within the same group and distinct expression profiles between the two groups ( Fig. 2A) . Comparing the osteogenic differentiated ASCs to undifferentiated cells, 1,460 lncRNAs were upregulated and 1,112 lncRNAs were downregulated (Fold change ≥ 2.0, P < 0.05) (Fig. 2B) . Among these, the expression of 88 lncRNAs were altered >10-fold in each pair of samples, including 55 upregulated and 33 downregulated genes. Specifically, the most upregulated lncRNA was uc002lbc.1 (Fold change: 84.37) and the most downregulated was uc.247+ (Fold change: 82.20) ( Table 1 ). The microarray data was submitted to the Gene Expression Omnibus (Accession number: GSE89330).
Differentially expressed mRNAs in osteogenic differentiated human ASCs
A total of 21,591 mRNAs were identified by microarray analysis, with the differentially expressed mRNA profile revealing that 946 mRNAs were upregulated and 1,640 mRNAs were downregulated during osteogenic differentiation (Fold change ≥ 2.0, P < 0.05) (Fig.   Fig. 2 . LncRNA and mRNA expression profiles based on microarray data. Hierarchical Clustering results show a distinguishable lncRNA (A) and mRNA (C) expression profile between the two groups and homogeneity within the same group. "Value" stands for the gene expression. The number "5" represents a relatively low expression level and is represented by the color green, whereas the number "9" represents a relatively high expression level and is represented by the color red in cluster maps. "Count" represents the number of genes that exhibited the same expression level. A total of 17,246 lncRNAs and 21,591 mRNAs were detected in human ASCs. Volcano Plots of lncRNAs (B) and mRNAs (D) in differentiated cells versus undifferentiated ASCs. Red squares in the plots represent the differentially expressed transcripts with statistical significance (Fold change ≥ 2.0, P < 0.05). Compared to undifferentiated ASCs, 2,572 lncRNAs and 2,586 mRNAs were significantly dysregulated. 2C-D). Of these, SLIT and NTRK like family member 1 (SLITRK1) was the most upregulated mRNA and Matrix metallopeptidase 3 (MMP3) was most downregulated (Table 2) .
GO analysis showed that the upregulated mRNAs were highly enriched in extracellular matrix organization (ontology: biological process), extracellular space (ontology: cellular component) and peptidase regulator activity (ontology: molecular function), and that the downregulated mRNAs were highly enriched in system development (ontology: biological process), cell periphery (ontology: cellular component) and protein binding (ontology: molecular Fig. S1 ). Pathway analysis revealed that the most highly enriched pathway for upregulated mRNAs was the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway and the most highly enriched pathway for downregulated mRNAs was the steroid biosynthesis network (see supplementary material, Fig. S2 ). Notably, there is mounting evidence suggesting that the PI3K/Akt pathway is involved in osteogenesis [24] [25] [26] .
Classification and subgroup analysis of differentially expressed lncRNAs
To obtain general signatures of dysregulated lncRNAs, we analyzed upregulated and downregulated lncRNAs according to classification and chromosome distribution. Based on the relative position of lncRNAs and the nearby coding genes on chromosomes, lncRNAs were divided into six categories including intergenic, natural antisense, intronic antisense, intron sense-overlapping, exon sense-overlapping and bidirectional. In our microarray data, the majority (60.34%) of the differentially expressed from microarray data were selected for validation by qRT-PCR in four paired undifferentiated and osteogenic differentiated human ASCs. For microarray analysis, the raw intensity of genes was quantile normalized. For qRT-PCR analysis, gene expression was normalized to GAPDH expression and calculated using the 2 -ΔΔCt method. The heights of the columns in the graph represent the mean fold changes (differentiated/undifferentiated) of expression. Paired t-test was used for comparison between undifferentiated and differentiated conditions. The expression of these lncRNAs as measured by microarray was significantly different between undifferentiated and differentiated cells (P < 0.001). *P < 0.05, **P < 0.01, ***P < 0.001 indicated differentiated vs. undifferentiated samples in qRT-PCR results.
lncRNAs were intergenic lncRNAs (Fig. 3A) . The upregulated and downregulated lncRNAs were dispersed in various chromosomes (Fig. 3B) .
Differentially expressed lncRNAs were further classified into subgroups including antisense lncRNAs, enhancer-like lncRNAs and long intergenic non-coding RNAs (lincRNAs). The associated mRNAs were also identified to help predict the potential function of these dysregulated lncRNAs. Over 30% of human transcripts have corresponding antisense lncRNAs and these lncRNAs exert biological functions by regulating their sense mRNAs [27] . Therefore, we identified 94 dysregulated antisense lncRNAs, as well as differentially expressed sense mRNAs, from our microarray data (Table 3) . Additionally, according to a previous study [28] , 85 enhancer-like lncRNAs were found to be differentially expressed during osteogenesis of human ASCs and the associated mRNAs were identified to explore the putative targets of these lncRNAs (Table 4) . Moreover, based on Cabili's work [29] , expression of 160 lincRNAs changed significantly at 14 days after osteogenic induction and the differentially expressed nearby coding genes were subsequently identified (Table 5) . 
qRT-PCR validation
In order to validate our microarray results, the expression of five upregulated lncRNAs (SAA3P, LOC284080, XLOC_001453, XLOC_011980 and HHIP-AS1) and five downregulated lncRNAs (XLOC_007489, CTC-564N23.3, XLOC_010397, XLOC_002619 and LINC00638) with fold changes >10.0 in the microarray profile were examined by qRT-PCR in four osteogenic differentiated human ASC cultures and paired undifferentiated cultures. Although the qRT-PCR results failed to confirm the expression pattern of XLOC_001453 and XLOC_002619, results for the other eight lncRNAs exhibited similar trends as those observed in the microarray data. Furthermore, the changes determined by qRT-PCR were significant (P < 0.05) and the fold changes measured by qRT-PCR correlated with that from microarray (r = 0.6121, P = 0.0334), demonstrating consistency between the qRT-PCR and microarray results (Fig. 4) . . Expression and function of H19 during osteogenic differentiation of human ASCs. A. Human ASCs were induced towards osteoblast differentiation for 7, 14 and 21 days, and expression of H19 was determined by qRT-PCR and compared to that at day 0. B-E. Human ASCs were transfected with scramble siRNA (NC) or H19 siRNA (si-H19-1, si-H19-2 and si-H19-3) or pEX-3 empty plasmid (pEX-3) or pEX-3-H19 for 48 hours, followed by induction of osteogenic differentiation for 3 days. Gene expression of H19 (B and C), and COL1A1, ALPL and RUNX2 (D and E) were measured by qRT-PCR and compared to that of NC or pEX-3. Gene expression was normalized to GAPDH expression and calculated by the 2-ΔΔCt method. Data was presented as mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 represent significant differences relative to control groups as determined by one-way ANOVA followed by Dunnett-t test or paired t-test. 
Construction of CNC network
In order to explore interactions among differentially expressed lncRNAs and mRNAs, a CNC network was constructed based on 55 upregulated and 33 downregulated lncRNAs exhibiting > 10-fold changes in all four pairs of samples. Pearson's correlation for each differentially expressed lncRNA and its paired mRNA was calculated and those transcripts with coefficients > 0.999 were chosen to build the network. In the CNC network, one lncRNA was able to correlate with different mRNAs, and vice versa. Transcripts exhibiting correlations with larger numbers of genes displayed greater degrees of connectivity and were considered as core regulatory factors. The lncRNAs with degrees ≥ 40 were further selected to construct a more visible network. The final CNC network comprised 12 lncRNAs and 157 mRNAs, with 645 network pairs (Fig. 5) . Both positive and negative correlations between lncRNAs and mRNAs were present, with detailed information regarding core regulatory lncRNAs shown in Table 6 .
Effects of lncRNA H19 on human ASCs osteogenesis
The expression of H19, which is upregulated and exhibits functions involved in osteogenic differentiation of human BMSCs [16, 18, 20] , was decreased (Fold change: 3.81) in osteogenic differentiated ASCs as compared with undifferentiated cells according to our microarray results. To validate the differences in these results and explore the possible function of H19 in ASCs, we measured dynamic H19 expression during osteogenic processes of human ASCs and examined the effect of H19 knockdown on osteogenesis of human ASCs. Consistent with our microarray results, expression of H19 was decreased significantly at days 7, 14 and 21 when compared with day 0 (Fig. 6A) . Additionally, qRT-PCR results confirmed significant inhibition of H19 expression following siRNA transfection, and significant enhancement of H19 expression following transfection with pEX-3-H19 plasmid (Fig. 6B, C) . Furthermore, knockdown of H19 resulted in significantly increased expression of RUNX2 and ALPL, but not COL1A1, during osteogenic induction of human ASCs (Fig. 6D) , whereas a significant decrease in expression of RUNX2 and ALPL was observed after H19 overexpression (Fig. 6E) .
Discussion
An understanding of the molecular mechanisms associated with osteogenesis is fundamental to maintaining osteogenic capacity and realizing the therapeutic potential of human ASCs. Although the functional roles of transcriptional factors, microRNAs and epigenetic factors in osteogenesis have been extensively studied [30] [31] [32] [33] [34] , few studies focused on the role and the underlying mechanisms of lncRNAs in this biological process [35] . Moreover, there is no report regarding genome-wide expression and function of lncRNAs in osteogenesis of ASCs. In the current study, we revealed the global expression profile of lncRNAs during osteogenic differentiation of human ASCs by microarray and predicted the potential function of the differentially expressed lncRNAs using bioinformatics analysis. In addition, our experimental evidence indicated that lncRNAs may play an important role in osteogenesis of human ASCs. We selected 10 lncRNAs for qRT-PCR validation of the microarray data. It was noticed that there was variations between lncRNA expression detected by qRT-PCR versus microarray. One explanation may be the inherent pitfalls in the differences between the two methods, including the different normalization procedures and priming methods used for reverse transcription [36] . However, expression of most of the lncRNAs selected for qRT-PCR validation showed similar trends as those observed in the microarray results. Moreover, statistical analysis indicated that the differences in lncRNA expression were significant between differentiated and undifferentiated human ASCs and the fold changes measured by qRT-PCR significantly correlated with those from microarray. Therefore, the qRT-PCR results confirmed the reliability of the microarray data.
Expression of some lncRNAs is altered during osteogenic differentiation of other kinds of MSCs [18, 21, 22] . Wang et al. [18] showed that 687 lncRNAs were significantly upregulated and 519 lncRNAs were significantly downregulated during osteogenesis of human BMSCs. Compared with those findings, we observed much more lncRNAs differentially expressed during osteogenesis of human ASCs. This might be explained by the different cell types used between the two studies, given that lncRNA expression is cell specific [14] . Another explanation could be the differences in microarray platforms utilized in the two studies. That used in this study included 30,586 lncRNAs and detected 17,246 lncRNAs expressed in human ASCs. Moreover, some previous studies investigated the function of particular lncRNA in osteogenesis. It was reported that suppression of lncRNA-ANCR could promote osteogenic differentiation of BMSCs [17] . However, we observed that expression of lncRNA-ANCR decreased slightly and without significance (Fold change: 1.14, P = 0.080) during osteogenesis of human ASCs according to our microarray results. Whether lncRNA-ANCR also plays an inhibitory role during osteogenic differentiation of ASCs requires further research. Recently, the Zhou group [23] reported that lncRNA-MIR31HG was induced by nuclear factor (NF)-κB activation in human ASCs and that lncRNA-MIR31HG, in turn, contributed to NF-κB activation, which further inhibited bone formation under inflammatory conditions. More importantly, in our current study, we found that lncRNA-MIR31HG was significantly downregulated (Fold change: 2.31, P = 0.000066) in osteogenic differentiated human ASCs when compared with undifferentiated cells. Therefore, these results suggested that during normal osteogenic differentiation of ASCs, downregulation of lncRNA-MIR31HG may be required, whereas in an inflammatory environment, MIR31HG may be pathologically upregulated to suppress bone formation. However, more specific experiments are required to test this hypothesis.
H19, one of the most well-known imprinted genes, encodes a 2.3-kb polyadenylated RNA that does not produce any known protein [37] . Several studies reported that H19 was upregulated during osteogenesis in BMSCs [16, 18, 20] . In addition, H19 promotes osteogenic differentiation of BMSCs via the transforming growth factor β-1/Smad3/histone deacetylase pathway, with microRNA (miR) -675 derived from H19 partially responsible for this pro-osteogenic effect [16] . However, another study showed that instead of promoting osteogenesis, miR-675-5p negatively regulates osteogenesis of BMSCs. The authors argued that this might be due to the negative-feedback loop associated with H19 and miR-675-5p. Meanwhile, they revealed another mechanism for H19 in the enhancement of osteogenic differentiation of BMSCs that concerned H19-mediated activation of Wnt signaling by acting as a microRNA sponge for miR-141 and miR-22, both of which negatively regulated β-catenin [20] . Here, we found that H19 expression decreased significantly during osteogenic differentiation of human ASCs. To the best of our knowledge, only one study showed reduced expression of H19 in ASCs as compared with BMSCs [38] ; however, no report exists regarding H19 expression during osteogenesis of ASCs. This discrepancy might be explained by evidence showing that H19 expression is regulated in a tissue-and cell-specific manner during embryogenesis [39] . However, the specific role of H19 in ASC osteogenesis has not been studied and it might be different from that of BMSCs, given its different expression patterns observed between the two cell types. In the present study, we showed that at early stage of osteogenesis of human ASCs, knockdown of H19 led to upregulation of osteogenesis-related genes, including RUNX2 and ALPL, while overexpression of H19 played a contrasting role. These findings suggested a negative regulatory role for H19 in early osteogenesis of human ASCs. It was reported that H19 also served as a competing endogenous RNA for the let-7 family of microRNAs and its deletion resulted in overexpression of let-7 [40] . Moreover, let-7 has been showed to enhance osteogenesis and suppress adipogenesis by negatively regulating high mobility group AT hook 2 (HMGA2) in ASCs [41] . Therefore, we attempted to determine whether H19 could act as a molecular sponge for let-7 to regulate the function of HMGA2 in ASCs. However, manipulation of H19 in vitro has no significant effects on expression of let-7 or HMGA2 during early stage of osteogenic differentiation of human ASCs (data not shown), which may imply that let-7 and HMGA2 are not targets of H19 during ASC osteogenesis. Therefore, further investigation to determine the direct targets and detailed mechanism of H19 during osteogenesis of human ASCs is required.
There were some limitations in the present study. First, we only chose cells after a 14-day osteogenic induction as osteogenic differentiated cells. This might result in losing information about the dynamic pattern of lncRNA expression over the course of the entire osteogenic process. However, this level of testing would be costly and increase the difficulty in comparing the gene expression profiles of different time points using microarray analysis. On the other hand, comparison of differentiated and undifferentiated stem cells has been widely used to investigate the differentiation process. Moreover, we monitored the expression of H19 at different time points during osteogenic induction and will measure the dynamic expression patterns of other candidate lncRNAs in future studies. Another limitation was that we did not identify the direct target of H19. Nonetheless, we have provided evidence of the potential role of H19 in early osteogenesis of human ASCs. Further studies will be conducted to investigate the detailed mechanism. Finally, although the study identifies H19 as a negative regulator of human ASC osteogenic differentiation, further studies are still required to determine what impact it has on matrix mineralization by ASC-derived osteoblasts.
In summary, to our knowledge, this is the first study revealing the comprehensive expression profiles of lncRNAs during osteogenic differentiation of human ASCs. The potential functions and mechanisms of the dysregulated lncRNAs were also investigated by bioinformatics analysis and lncRNA transfection experiments. Although the specific role and mechanism of these candidate lncRNAs in osteogenesis of human ASCs require further studies, our findings extended the information known about the osteogenic process of ASCs and suggested directions for further investigations on the regulation of osteoblastic differentiation of ASCs as well as treatments for osteoporosis and other bone diseases.
